Company Overview - The Scotts Miracle-Gro Company (NYSE:SMG) is a leading provider of branded lawn and garden products in North America and is recognized as a proxy for the cannabis industry through its Hawthorne Gardening subsidiary, which supplies hydroponic equipment and cultivation inputs to cannabis growers [4]. Financial Performance and Market Position - Wells Fargo raised its price target for The Scotts Miracle-Gro Company from $70 to $75, maintaining an Overweight rating, citing strong sector momentum and one of the strongest relative starts for Staples versus the S&P 500 on record [2]. Shareholder Engagement and Governance - At the January 26, 2026, virtual annual meeting, shareholders approved an amendment to the Long-Term Incentive Plan, increasing the pool of common shares available for grant by 2,750,000 shares. The company implemented new equity award agreements to align management and board incentives with shareholder value creation [3]. - Approximately 91% of outstanding shares were represented at the meeting, indicating strong shareholder engagement in governance matters [3].

Industry Overview - The U.S. cannabis industry is projected to generate over $30 billion in annual sales in 2024, with expectations to exceed $50 billion by 2030 due to expanding legalization and rising consumer demand [1] - Recent bipartisan discussions in Congress aim to improve banking access for cannabis businesses, potentially boosting profitability [1] - Ancillary cannabis companies, which provide products and services to cultivators and retailers, benefit from sector growth while avoiding direct plant-touching risks [1][3] Company Highlights - **GrowGeneration (GRWG)**: Operates the largest chain of hydroponic and organic gardening stores in the U.S., reporting net sales of $41 million in Q2 2025, a 14.7% increase from the prior quarter, despite a year-over-year revenue decline [5][8] - **Hydrofarm Holdings Group (HYFM)**: Manufactures and distributes hydroponics equipment, with 2024 revenue of $190.29 million, down 16% from 2023. The company is set to release Q2 2025 results, with a focus on stabilizing revenue [9] - **Scotts Miracle-Gro (SMG)**: Generated approximately $3.55 billion in total revenue in 2024, with a significant improvement in net loss to $34.9 million. The Hawthorne division faced a 35% decline in sales, but the company plans to divest this unit to reduce volatility [10][13] Investment Considerations - Ancillary cannabis stocks like GrowGeneration, Hydrofarm, and Scotts Miracle-Gro provide exposure to the cannabis market while avoiding the complexities of direct sales [14] - GrowGeneration is noted for improving margins and effective cost management, while Hydrofarm is viewed as a watch-and-see opportunity pending upcoming earnings [15] - Scotts Miracle-Gro's planned divestiture of the Hawthorne unit may reshape its market exposure, focusing on core operations for more predictable growth [15]